Free Trial

H.B. Fuller (FUL) Competitors

H.B. Fuller logo
$62.14 -0.08 (-0.13%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FUL vs. ALB, CE, BCPC, NEU, ASH, SXT, IOSP, MTX, KWR, and SCL

Should you be buying H.B. Fuller stock or one of its competitors? The main competitors of H.B. Fuller include Albemarle (ALB), Celanese (CE), Balchem (BCPC), NewMarket (NEU), Ashland (ASH), Sensient Technologies (SXT), Innospec (IOSP), Minerals Technologies (MTX), Quaker Chemical (KWR), and Stepan (SCL). These companies are all part of the "specialty chemicals" industry.

H.B. Fuller vs.

Albemarle (NYSE:ALB) and H.B. Fuller (NYSE:FUL) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, community ranking, earnings, valuation and profitability.

In the previous week, H.B. Fuller had 24 more articles in the media than Albemarle. MarketBeat recorded 26 mentions for H.B. Fuller and 2 mentions for Albemarle. Albemarle's average media sentiment score of 0.50 beat H.B. Fuller's score of -0.04 indicating that Albemarle is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Albemarle
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
H.B. Fuller
4 Very Positive mention(s)
4 Positive mention(s)
8 Neutral mention(s)
6 Negative mention(s)
1 Very Negative mention(s)
Neutral

Albemarle has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500. Comparatively, H.B. Fuller has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500.

92.9% of Albemarle shares are held by institutional investors. Comparatively, 95.9% of H.B. Fuller shares are held by institutional investors. 0.4% of Albemarle shares are held by company insiders. Comparatively, 2.0% of H.B. Fuller shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Albemarle received 459 more outperform votes than H.B. Fuller when rated by MarketBeat users. Likewise, 62.80% of users gave Albemarle an outperform vote while only 55.63% of users gave H.B. Fuller an outperform vote.

CompanyUnderperformOutperform
AlbemarleOutperform Votes
775
62.80%
Underperform Votes
459
37.20%
H.B. FullerOutperform Votes
316
55.63%
Underperform Votes
252
44.37%

Albemarle has higher revenue and earnings than H.B. Fuller. Albemarle is trading at a lower price-to-earnings ratio than H.B. Fuller, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Albemarle$9.62B1.19$1.57B-$16.75-5.82
H.B. Fuller$3.51B0.97$144.91M$3.2419.18

H.B. Fuller has a net margin of 5.15% compared to Albemarle's net margin of -28.80%. H.B. Fuller's return on equity of 13.39% beat Albemarle's return on equity.

Company Net Margins Return on Equity Return on Assets
Albemarle-28.80% 1.67% 0.84%
H.B. Fuller 5.15%13.39%4.97%

Albemarle presently has a consensus price target of $115.65, suggesting a potential upside of 18.60%. H.B. Fuller has a consensus price target of $84.20, suggesting a potential upside of 35.50%. Given H.B. Fuller's higher probable upside, analysts clearly believe H.B. Fuller is more favorable than Albemarle.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Albemarle
1 Sell rating(s)
15 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.26
H.B. Fuller
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 1.7%. H.B. Fuller pays an annual dividend of $0.89 per share and has a dividend yield of 1.4%. Albemarle pays out -9.7% of its earnings in the form of a dividend. H.B. Fuller pays out 27.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has increased its dividend for 30 consecutive years and H.B. Fuller has increased its dividend for 56 consecutive years. Albemarle is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Albemarle beats H.B. Fuller on 11 of the 21 factors compared between the two stocks.

Get H.B. Fuller News Delivered to You Automatically

Sign up to receive the latest news and ratings for FUL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FUL vs. The Competition

MetricH.B. FullerAdhesives & sealants IndustryMaterials SectorNYSE Exchange
Market Cap$3.35B$3.15B$2.87B$19.27B
Dividend Yield1.45%0.86%5.10%3.72%
P/E Ratio19.1818.05110.3441.41
Price / Sales0.973.09880,235.4017.05
Price / Cash8.8023.5624.3119.84
Price / Book1.914.003.765.76
Net Income$144.91M$79.87M$153.38M$993.25M
7 Day Performance1.53%3.10%1.57%3.26%
1 Month Performance-10.99%-0.95%3.91%5.22%
1 Year Performance-20.40%20.11%26.65%19.42%

H.B. Fuller Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FUL
H.B. Fuller
4.1114 of 5 stars
$62.14
-0.1%
$76.50
+23.1%
-20.4%$3.35B$3.51B19.187,200Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
ALB
Albemarle
3.6452 of 5 stars
$90.18
+4.2%
$115.84
+28.5%
-17.4%$10.60B$6.50B-5.387,400Analyst Forecast
CE
Celanese
4.8663 of 5 stars
$66.95
+3.0%
$108.22
+61.6%
-50.1%$7.32B$10.48B6.7412,410Analyst Upgrade
News Coverage
BCPC
Balchem
4.744 of 5 stars
$154.70
+0.3%
$190.00
+22.8%
+14.7%$5.03B$942.38M41.591,302
NEU
NewMarket
2.2691 of 5 stars
$486.87
+0.8%
N/A-16.7%$4.67B$2.78B10.812,000
ASH
Ashland
4.8685 of 5 stars
$68.85
-0.1%
$102.00
+48.1%
-9.1%$3.24B$2.11B20.553,200Short Interest ↑
SXT
Sensient Technologies
4.0029 of 5 stars
$67.77
+0.7%
$85.00
+25.4%
+21.8%$2.87B$1.53B32.433,956Dividend Announcement
News Coverage
IOSP
Innospec
3.0659 of 5 stars
$106.52
+1.2%
N/A-2.4%$2.66B$1.87B18.592,100
MTX
Minerals Technologies
3.3668 of 5 stars
$73.09
+1.6%
N/A+16.0%$2.33B$2.12B15.494,070Positive News
KWR
Quaker Chemical
4.4164 of 5 stars
$127.74
+2.1%
$177.33
+38.8%
-30.0%$2.27B$1.86B18.734,400
SCL
Stepan
3.7441 of 5 stars
$61.70
+2.4%
N/A-28.8%$1.39B$2.19B30.702,389Analyst Downgrade
Short Interest ↑

Related Companies and Tools


This page (NYSE:FUL) was last updated on 1/19/2025 by MarketBeat.com Staff
From Our Partners